Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

O&G TopicsReproductive endocrinology & infertility

O&G · Reproductive endocrinology & infertility

Male-factor infertility

Also known as Male infertility · Male subfertility · Azoospermia · Oligozoospermia · Surgical sperm retrieval · ICSI

Exam-exhaustive FRANZCOG fellowship topic on male-factor infertility. Covers the WHO 6th-edition (2021) semen reference limits, the pre-testicular/testicular/post-testicular framework, the endocrine panel, the obstructive-versus-non-obstructive azoospermia distinction, the genetic cascade (karyotype, Y-chromosome microdeletion, CFTR), the management ladder (lifestyle, varicocele repair, gonadotrophins for hypogonadotropic hypogonadism, surgical sperm retrieval — TESE/MESA/PESA — for obstructive azoospermia, donor sperm), the IVF/ICSI pathway, and the killer pitfalls including exogenous testosterone as a contraceptive. RANZCOG-primary, globally tagged to MRCOG and ABOG.

high15 referencesUpdated 1 Aug 202614 min readVerification in progress

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI

Red flags

  • Azoospermia or severe oligozoospermia — repeat urgently and start the genetic workup (karyotype, Y microdeletion) before ART
  • A man on exogenous testosterone who wishes to conceive — testosterone suppresses the HPG axis and causes azoospermia; stop it and switch to gonadotrophins
  • Absent vas deferens on examination — congenital bilateral absence of the vas deferens (CBAVD); CFTR screen the man AND his partner before ART
  • Complete AZFa or AZFb Y-microdeletion — surgical sperm retrieval will fail; counsel the couple towards donor sperm before consenting to retrieval
  • Rapid-onset asymmetry, a hard testicular mass, or new testicular pain in a subfertile man — exclude a testicular tumour before any fertility treatment
  • Visual field defect or headaches with low testosterone — exclude a pituitary macroadenoma before hormonal therapy
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

FRANZCOGMRCOGABOGFRCSCMRCPI

Red flags

  • Azoospermia or severe oligozoospermia — repeat urgently and start the genetic workup (karyotype, Y microdeletion) before ART
  • A man on exogenous testosterone who wishes to conceive — testosterone suppresses the HPG axis and causes azoospermia; stop it and switch to gonadotrophins
  • Absent vas deferens on examination — congenital bilateral absence of the vas deferens (CBAVD); CFTR screen the man AND his partner before ART
  • Complete AZFa or AZFb Y-microdeletion — surgical sperm retrieval will fail; counsel the couple towards donor sperm before consenting to retrieval
  • Rapid-onset asymmetry, a hard testicular mass, or new testicular pain in a subfertile man — exclude a testicular tumour before any fertility treatment
  • Visual field defect or headaches with low testosterone — exclude a pituitary macroadenoma before hormonal therapy
One-line fellowship answer

Male-factor infertility is present in roughly half of infertile couples. Assess the man in parallel with the woman: two semen analyses against the WHO 6th-edition limits, a targeted endocrine panel, and the pre-testicular/testicular/post-testicular framework. Distinguish obstructive from non-obstructive azoospermia, run the genetic cascade when the count is severely low, and escalate from lifestyle correction to gonadotrophins (for hypogonadotropic hypogonadism), surgical sperm retrieval and IVF/ICSI. Never give exogenous testosterone to a man who wants to conceive.[1][4][5]

A couple sits in your fertility clinic. They have been trying for 18 months. The woman has had her day-3 hormones, her cycle is regular, and her tubes are patent — and the first semen report comes back at 3 million per mL. The temptation is to send the man to the urologist and wait. Resist it. Male factor is assessed in parallel with the female workup, it carries its own genetic obligations, and the single most dangerous prescription in the room — exogenous testosterone — feels like a kindness to a man with low libido and is, in fact, a contraceptive. This topic is the structured way through.[3][14]

Overview and definition

Infertility is the failure to achieve a clinical pregnancy after 12 months of regular unprotected intercourse; evaluation begins earlier — at 6 months — when the woman is over 35 or there is a known male risk. Male factor is involved in about half of all infertile couples: an isolated male factor in roughly 20% and a combined male-plus-female factor in a further 30%.[3][4]

Two principles frame everything that follows: [4][14]

  • Parallel, not serial. Order the semen analysis, the female day-2/3 hormones and AMH, and the ovulation and tubal assessment at the same time. A man investigated only after the woman is "cleared" has lost months he could not afford.
  • A semen defect is a descriptor, not a diagnosis. Oligozoospermia, asthenozoospermia and teratozoospermia describe what is abnormal — they do not say why. Your job is to find the why: pre-testicular, testicular, or post-testicular.[4]
Obstetrics & Gynaecology Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Obstetrics & Gynaecology fellowship library.

Sign in to continueSee pricing
References15ShowHide
  1. [1]Cooper TG, Noonan E, von Eckardstein S, et al. World Health Organization reference values for human semen characteristics Hum Reprod Update, 2010.PMID 19934213
  2. [2]Boitrelle F, Shah R, Saleh R, et al. The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis Life (Basel), 2021.PMID 34947899
  3. [3]Agarwal A, Mulgund A, Hamada A, et al. A unique view on male infertility around the globe Reprod Biol Endocrinol, 2015.PMID 25928197
  4. [4]Practice Committee of the American Society for Reproductive Medicine Diagnostic evaluation of the infertile male: a committee opinion Fertil Steril, 2012.PMID 22698639
  5. [5]Palermo G, Joris H, Devroey P, et al. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte Lancet, 1992.PMID 1351601
  6. [6]Practice Committee of the American Society for Reproductive Medicine; Society for Male Reproduction and Urology Report on varicocele and infertility: a committee opinion Fertil Steril, 2014.PMID 25458620
  7. [7]Kroese AC, de Lange NM, Collins J, et al. Surgery or embolization for varicoceles in subfertile men Cochrane Database Syst Rev, 2012.PMID 23076888
  8. [8]Showell MG, Mackenzie-Proctor R, Brown J, et al. Antioxidants for male subfertility Cochrane Database Syst Rev, 2014.PMID 25504418
  9. [9]Practice Committee of the American Society for Reproductive Medicine Management of nonobstructive azoospermia: a committee opinion Fertil Steril, 2018.PMID 30503112
  10. [10]Practice Committee of the American Society for Reproductive Medicine; Society for Male Reproduction and Urology The management of obstructive azoospermia: a committee opinion Fertil Steril, 2019.PMID 31029241
  11. [11]Vloeberghs V, Verheyen G, Haentjens P, et al. How successful is TESE-ICSI in couples with non-obstructive azoospermia? Hum Reprod, 2015.PMID 26082482
  12. [12]Page ST, Amory JK, Anawalt BD, et al. Testosterone gel combined with depomedroxyprogesterone acetate is an effective male hormonal contraceptive regimen and is not enhanced by the addition of a GnRH antagonist J Clin Endocrinol Metab, 2006.PMID 16940442
  13. [13]Sharma R, Harlev A, Agarwal A, et al. Cigarette Smoking and Semen Quality: A New Meta-analysis Examining the Effect of the 2010 World Health Organization Laboratory Methods for the Examination of Human Semen Eur Urol, 2016.PMID 27113031
  14. [14]Björndahl L, Barratt CLR, Mortimer D, et al. Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology Hum Reprod, 2022.PMID 36112046
  15. [15]Omar MI, Pal RP, Kelly BD, et al. Benefits of Empiric Nutritional and Medical Therapy for Semen Parameters and Pregnancy and Live Birth Rates in Couples with Idiopathic Infertility: A Systematic Review and Meta-analysis Eur Urol, 2019.PMID 30630643

Test yourself

Practise what you just read

  • 8 MCQs
Obstetrics & Gynaecology Pro

$29/ monthor $279 / year

The complete Obstetrics & Gynaecology library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousMale infertility: structured assessment, WHO 6th-edition (2021) semen criteria, endocrine panel, genetic cascade, and ART pathwayReproductive endocrinology & infertilityNextOHSS and fertility-treatment complications — Golan grading, VEGF pathophysiology, prophylaxis (cabergoline, GnRH antagonist trigger), and ICU managementReproductive endocrinology & infertility